Reports related to this article:
Project(s): View 3 related projects in PECWeb
Plant(s): View 3 related plants in PECWeb
en
Researched by Industrial Info Resources (Sugar Land, Texas)--The combination of Bayer Group AG (Leverkusen, Germany) and Monsanto Company (NYSE:MON) (St. Louis, Missouri) would encompass $3.5 billion in active projects being tracked by Industrial Info, spanning the Chemical Processing, Pharmaceutical & Biotech and Food & Beverage industries. Bayer laid out some of the details of the proposed $62 billion acquisition of Monsanto on Monday.
Bayer said in a press release the proposed $62 billion acquisition would create a "leading integrated agriculture business with broad product portfolio and exceptional R&D [research and development] pipeline to deliver valuable and innovative solutions for farmers," while reinforcing Bayer as a global life science company. The combined business would have its global Seeds & Traits and North American commercial headquarters in St. Louis, Missouri, its global Crop Protection and divisional Crop Science headquarters in Monheim, Germany, and a presence in Durham, North Carolina. Its digital farming business, which helps farmers make better use of data collected on their own operations, would be based near San Francisco, California. Bayer said it has 116,800 employees globally, including more than 12,500 employees in the U.S. Monsanto has 22,500 employees globally.
Industrial info is tracking 59 active Bayer projects across the globe worth $2.13 billion and 28 active Monsanto projects worth $1.37 billion. Bayer CropSciences AG's $200 million herbicide plant addition at Theodore, Alabama, will produce glufosinate-ammonium. Project completion is planned for late 2017. Monsanto's planned dicamba herbicide plant expansion in Luling, Louisiana, has an estimated total investment value (TIV) of $975 million. Jacobs Engineering Group Incorporated (NYSE:JEC) (Pasadena, California) is serving as the project's engineering, procurement and construction (EPC) contractor. Construction would kick off in third-quarter 2017, with completion in second-quarter 2019.
One of Bayer's U.S. biotech-pharma projects is the $100 million Blood Disorder Therapies Product Testing Lab Building 88 addition in Berkeley, California. Construction of the 80,000-square-foot building began in second-quarter 2015, with completion planned for fourth-quarter 2017.
Industrial Info Resources (IIR), with global headquarters in Sugar Land, Texas, five offices in North America and 10 international offices, is the leading provider of global market intelligence specializing in the industrial process, heavy manufacturing and energy markets. Industrial Info's quality-assurance philosophy, the Living Forward Reporting Principle, provides up-to-the-minute intelligence on what's happening now, while constantly keeping track of future opportunities. Follow IIR on: Facebook - Twitter - LinkedIn. For more information on our coverage, send inquiries to info@industrialinfo.com or visit us online at http://www.industrialinfo.com/.
Bayer said in a press release the proposed $62 billion acquisition would create a "leading integrated agriculture business with broad product portfolio and exceptional R&D [research and development] pipeline to deliver valuable and innovative solutions for farmers," while reinforcing Bayer as a global life science company. The combined business would have its global Seeds & Traits and North American commercial headquarters in St. Louis, Missouri, its global Crop Protection and divisional Crop Science headquarters in Monheim, Germany, and a presence in Durham, North Carolina. Its digital farming business, which helps farmers make better use of data collected on their own operations, would be based near San Francisco, California. Bayer said it has 116,800 employees globally, including more than 12,500 employees in the U.S. Monsanto has 22,500 employees globally.
Industrial info is tracking 59 active Bayer projects across the globe worth $2.13 billion and 28 active Monsanto projects worth $1.37 billion. Bayer CropSciences AG's $200 million herbicide plant addition at Theodore, Alabama, will produce glufosinate-ammonium. Project completion is planned for late 2017. Monsanto's planned dicamba herbicide plant expansion in Luling, Louisiana, has an estimated total investment value (TIV) of $975 million. Jacobs Engineering Group Incorporated (NYSE:JEC) (Pasadena, California) is serving as the project's engineering, procurement and construction (EPC) contractor. Construction would kick off in third-quarter 2017, with completion in second-quarter 2019.
One of Bayer's U.S. biotech-pharma projects is the $100 million Blood Disorder Therapies Product Testing Lab Building 88 addition in Berkeley, California. Construction of the 80,000-square-foot building began in second-quarter 2015, with completion planned for fourth-quarter 2017.
Industrial Info Resources (IIR), with global headquarters in Sugar Land, Texas, five offices in North America and 10 international offices, is the leading provider of global market intelligence specializing in the industrial process, heavy manufacturing and energy markets. Industrial Info's quality-assurance philosophy, the Living Forward Reporting Principle, provides up-to-the-minute intelligence on what's happening now, while constantly keeping track of future opportunities. Follow IIR on: Facebook - Twitter - LinkedIn. For more information on our coverage, send inquiries to info@industrialinfo.com or visit us online at http://www.industrialinfo.com/.
